Literature DB >> 9694583

Diagnostic effectiveness of TSH screening and of T4 with secondary TSH screening for newborn congenital hypothyroidism.

S T Wang1, S Pizzolato, H P Demshar.   

Abstract

We used a receiver operating characteristic (ROC) plot to evaluate the diagnostic accuracy of primary thyrotropin (TSH) screening, and compared it to the primary thyroxine (T4) with secondary TSH screening (T4/TSH) on a certain percentage of the lowest T4 value for newborn congenital hypothyroidism (CH). There were 2198 normal and 117 abnormal CH cases evaluated using both the Wallac Delfia neonatal TSH and neonatal T4 kits. The ROC areas of the primary TSH screening and T4/TSH screening were 0.9841 and 0.9557, respectively. Nine cases (out of 117 cases) of CH would have been misclassified if T4/TSH screening were used. These nine cases, however, were identified using primary TSH screening. We conclude that using primary TSH screening is more effective for mass screening in reducing false-positive and false-negative cases than the combined T4/TSH screening method.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694583     DOI: 10.1016/s0009-8981(98)00057-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research.

Authors:  Rachel L Derr; Scott J Cameron; Sherita Hill Golden
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

2.  Performance metrics after changes in screening protocol for congenital hypothyroidism.

Authors:  Steven J Korzeniewski; Violanda Grigorescu; Mary Kleyn; William Young; Gretchen L Birbeck; David Todem; Roberto Romero; Tinnakorn Chaiworapongsa; Nigel Paneth
Journal:  Pediatrics       Date:  2012-10-08       Impact factor: 7.124

3.  Treatment and follow-up of children with transient congenital hypothyroidism.

Authors:  Ru-lai Yang; Zhi-wei Zhu; Xue-lian Zhou; Zheng-yan Zhao
Journal:  J Zhejiang Univ Sci B       Date:  2005-12       Impact factor: 3.066

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.